Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972139priorityCriticalpatent/ECSP972139A/en
Publication of ECSP972139ApublicationCriticalpatent/ECSP972139A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Conjugados PEG-IFN alfa fisiológicamente activos, con la siguiente fórmula:(gráfico)Physiologically active PEG-IFN alpha conjugates, with the following formula: (graph)
ECSP9721391997-05-291997-05-29
INTERFERON CONJUGATES (CASE RAN 410077)
ECSP972139A
(en)
Pharmaceutical composition comprising a pegylated conjugate of interferon alfa and ribavirin, useful in the preparation of a medicament for chronic hepatitis C infections.